Class A GPCR heterodimers: evidence from binding studies

被引:52
作者
Birdsall, Nigel J. M. [1 ]
机构
[1] Natl Inst Med Res, Div Phys Biochem, MRC, London NW7 1AA, England
基金
英国医学研究理事会;
关键词
DOPAMINE D2 RECEPTORS; MUSCARINIC RECEPTORS; CANNABINOID CB1; PROTEIN; OLIGOMERIZATION; LIGANDS; IDENTIFICATION; ACETYLCHOLINE; PHARMACOLOGY; STIMULATION;
D O I
10.1016/j.tips.2010.08.003
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
There is a large body of experimental evidence that is compatible with the presence of heterodimers of the major A subclass of G protein-coupled receptors (GPCRs) and suggests that these heterodimers might have different functional properties from those of the monomers (or homodimers) of the individual receptors that engage in heterodimer formation. The question is whether there are allosteric interactions across the receptor-receptor interface of a heterodimer that modulate the binding properties of the heterodimer components and thereby change their pharmacology. In this review, I examine published experimental evidence from radioligand binding studies in the context of different models of allosterism and discuss a number of apparently discrepant results. The analysis suggests that more experimental data are required if equal, two-way, crossreceptor interactions within a GPCR heterodimer, at the level of binding, are to be unequivocally demonstrated.
引用
收藏
页码:499 / 508
页数:10
相关论文
共 45 条
  • [1] Allosterism at muscarinic receptors: Ligands and mechanisms
    Birdsall, NJM
    Lazareno, S
    [J]. MINI-REVIEWS IN MEDICINAL CHEMISTRY, 2005, 5 (06) : 523 - 543
  • [2] CAN DIFFERENT RECEPTORS INTERACT DIRECTLY WITH EACH OTHER
    BIRDSALL, NJM
    [J]. TRENDS IN NEUROSCIENCES, 1982, 5 (05) : 137 - 138
  • [3] The apparent cooperativity of some GPCRs does not necessarily imply dimerization
    Chabre, Marc
    Deterre, Philippe
    Antonny, Bruno
    [J]. TRENDS IN PHARMACOLOGICAL SCIENCES, 2009, 30 (04) : 182 - 187
  • [4] Heterodimerization of type A and B cholecystokinin receptors enhance signaling and promote cell growth
    Cheng, ZJ
    Harikumar, KG
    Holicky, EL
    Miller, LJ
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (52) : 52972 - 52979
  • [5] How to impose microscopic: Reversibility in complex reaction mechanisms
    Colquhoun, D
    Dowsland, KA
    Beato, M
    Plested, AJR
    [J]. BIOPHYSICAL JOURNAL, 2004, 86 (06) : 3510 - 3518
  • [6] Dorsch S, 2009, NAT METHODS, V6, P225, DOI [10.1038/NMETH.1304, 10.1038/nmeth.1304]
  • [7] Analysis of allosterism in functional assays
    Ehlert, FJ
    [J]. JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS, 2005, 315 (02) : 740 - 754
  • [8] EHLERT FJ, 1988, MOL PHARMACOL, V33, P187
  • [9] Evidence for negative binding cooperativity within CCR5-CCR2b heterodimers
    El-Asmar, L
    Springael, JY
    Ballet, S
    Andrieu, EU
    Vassart, G
    Parmentier, M
    [J]. MOLECULAR PHARMACOLOGY, 2005, 67 (02) : 460 - 469
  • [10] Orexin-1 receptor-cannabinoid CB1 receptor heterodimerization results in both ligand-dependent and -independent coordinated alterations of receptor localization and function
    Ellis, James
    Pediani, John D.
    Canals, Meritxell
    Milasta, Sandra
    Milligan, Graeme
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2006, 281 (50) : 38812 - 38824